Diabetes in practice : case studies with commentary / Boris Draznin, MD, PhD, editor.

Format:

Book

Contributor:

Draznin, Boris, editor.

Louis B. Flexner Medical Book Fund.

Language:

English

Subjects (All):

Diabetes.

Diabetes--Case studies.

Genre:

Case studies.

Physical Description:

ix, 222 pages : illustrations (some color) ; 23 cm

Place of Publication:

Alexandria, Virginia : American Diabetes Association, [2021]

Contents:

Part 1 Atypical Diabetes

Case 1 Suspected Maturity-Onset Diabetes of the Young (MODY)-5 (MODY-HNF1B) Responding to Monotherapy with Metformin p. 2 / Ana Ramirez Berlioz, MD and Richa Patel, MD and David Gardner, MD and L. Romayne Kurukulasuriya, AID and James Sowers, MD

Case 2 Maturity-Onset Diabetes of the Young (MODY)-4 Presenting as Gestational Diabetes p. 5 / Ivana Sheu and Yung-In Choi and Samar Singh and Ping H. Wang

Case 3 Does This Patient have Type 1 or Type 2 Diabetes? p. 8 / Zubina Unjom and Janice L. Gilden

Case 4 Is This an Unusual Type of Diabetes? p. 12 / Nitish Singh Nandu and Andriy Havrylyan and Janice L. Gilden and Bushra Osmani

Case 5 Challenges in the Management of Pancreatogenic (Type 3 c) Diabetes p. 16 / Katrina Plan and Janet B. McGill

Case 6 New-Onset Diabetes as a Symptom of Pancreatic Adenocarcinoma p. 20 / Emily Gammoh and Jagdeesh Ullal

Case 7 Sweet's Syndrome in a Patient With Diabetes p. 23 / Nitish Singh Nandu and Sabah Patel and Janice L. Gilden

Case 8 Wolcott-Rallison Syndrome p. 29 / Mehmet N. Özbek and Eda Cengiz

Case 9 Glucose Intolerance Associated with ACTH-Dependent Cushing's Disease p. 33 / Nitya K. Kumar and Susan Spratt

Case 10 Maturity-Onset Diabetes of the Young (MODY) Misdiagnosis as Steroid-Induced Diabetes p. 37 / Ghada Elshimy and Ricardo Correa

Part 2 Diabetic Ketoacidosis (DKA) and Euglycemic DKA

Case 11 A Case of Histiocytosis-Lymphadenopathy Plus Syndrome Due to a Novel Mutation in the SLC29A3 Gene and Presentation With Diabetic Ketoacidosis p. 42 / Gül Yesiltepe-Mutlu and Mehmet N. Özbek and Eda Cengiz

Case 12 Acromegaly Presenting With Diabetic Ketoacidosis p. 47 / Ritika Verma and K. Huynh and R. Gundluru and M. Gardner and James Sowers

Case 13 Rapid-Onset Type 1 Diabetes and Ketoacidosis p. 50 / Deepthi Rimmalapudi and Eli Ipp

Case 14 Euglycemic Ketoacidosis in the Setting of COVID-19 Infection and Sodium-Glucose Cotransporter 2 Inhibitor Use p. 54 / Olga Duchon and Celeste Thomas

Case 15 Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitor Use p. 58 / Diana Soliman and Nicole Jelesoff

Case 16 A Case of Euglycemic Diabetic Ketoacidosis After Initiation of Ketogenic Diet in a Patient With Type 2 Diabetes on a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor p. 62 / Matthew P. Gilbert and Amy Shah

Case 17 Diabetic Ketoacidosis in End-Stage Renal Disease: A Unique Challenge p. 66 / Vishnu Garla and Angela Subauste and Lillian F. Lien

Case 18 Euglycemic Diabetic Ketoacidosis in a Patient With Type 1 Diabetes Treated With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor While on a Ketogenic Diet p. 71 / Jessica Castellanos-Diaz and Julio Leey-Casella and Kenneth Cusi and Sushma Kadiyala

Part 3 Cancer Therapy and Diabetes

Case 19 Immune Checkpoint Inhibitor-Induced Type 1 Diabetes p. 77 / Halis Kaan Akturk and Aaron W. Michels

Case 20 Partial B-Cell Destruction: An Atypical Case of Immune Checkpoint Inhibitor Diabetes p. 80 / Zoe Quandt and Paras Mehta and Katy K. Tsai and Victoria Hsiao and Robert J. Rushakoff

Case 21 Checkpoint Inhibitor-Induced Diabetes p. 83 / Paras Mehta and Zoe Quandt and Robert J. Rushakoff

Case 22 Alpelisib-Induced Hyperglycemia: A Case Series p. 86 / Richa Patel and Ana Ramirez Berlioz and Amber Pinson and Michael Gardner

Case 23 Phospharidylinositol 3-Kinase (PI3K) Inhibitor-Induced Hyperglycemia p. 90 / Sanjita B. Chittimoju and Sara M. Alexanian and Katherine L. Modzelewski

Part 4 Autoimmunity and Diabetes

Case 24 Misleading Diabetes: A Case of Type B Insulin Resistance Associated With Lupus Nephritis and Autoimmune Hepatitis p. 97 / Ghada Elshimy and Mary Esquivel and Meredith McFarland and Jessica Ricciuto and Christopher Tessier and Joanna Miragaya and Ricardo Correa

Case 25 Latent Autoimmune Diabetes in an Adult With Insulin Allergy p. 103 / Makeda Dawkins and Alyson K. Myers

Case 26 Onset of Autoimmune Diabetes During Pregnancy p. 107 / Kaitlyn Barrett and Kelsey Sheahan and Matthew P. Gilbert

Case 27 Comorbidity of Diabetes and Systemic Lupus Erythematosus p. 111 / Boris Mankovsky and Yanina Saenko

Case 28 Illusion of Autoimmune Diabetes p. 114 / Nay Linn Aung

Case 29 Can a Lupus Flare Cause Autoimmune Diabetes? p. 118 / Andriy Havrylyan and Janice L. Gilden

Part 5 Continuous Glucose Monitoring (CGM) and Insulin Pumps

Case 30 Feasibility and Utility of Continuous Glucose Monitoring in an Adult with Type 1 Diabetes and Down's Syndrome p. 123 / Kristen L. Flint and Elena Toschi

Case 31 A Novel Approach to Achieve Target Time in Range When Using U-500 Regular Insulin in a Continuous Subcutaneous Insulin Infusion (CSLT) Pump p. 127 / Patricia A. Montesinos and Michelle F. Magee

Case 32 Automated Insulin Infusion System Is Useful to Control Blood Glucose Concentration During Major Stress in Patients with Type 1 Diabetes p. 132 / Renzo Cordera and Davide Maggi

Case 33 Detecting Patterns in Continuous Glucose Monitoring of Glucocorticoid-Treated Patients With Diabetes p. 135 / Harjyot Sandhu and Janice L. Gilden and Lynne Wentz

Part 6 Hypoglycemia

Case 34 Hyperinsulemic Hypoglycemia After Roux-en-Y Gastric Bypass Surgery: Both Fasting and Postprandial p. 143 / Maria Magar and Anne Peters and Braden Barnett

Case 35 Refractory Hypoglycemia Due to Massive Unintentional Insulin Overdose p. 145 / Jennifer D. Merrill and Jennifer Rowell

Case 36 A Case of Prolonged Hypoglycemia Due to Sulfonylurea and Concurrent Antibiotic Use p. 150 / Jennifer D. Merrill and Susan E. Spratt

Part 7 Cystic Fibrosis-Related Diabetes (CFRD)

Case 37 "Do I Really Need Insulin? "The Role of Insulin Therapy in Cystic Fibrosis-Related Diabetes (CFRD) p. 155 / Nader Kasim and Antoinette Moran and Amir Moheet

Case 38 Cystic Fibrosis-Related Diabetes Case Series: Effects of the CF Transmembrane Conductance Regulator (CFTR) Modulator on Glycemic Control p. 158 / Jagdeesh Ullal and Lina Merjaneh and Kara S. Hughan and Andrea Kelly

Part 8 Diabetes Management and Miscellaneous Cases

Case 39 Simplifying Insulin Therapy: Transitioning from Basal-Bolus Insulin Therapy to Basal Insulin With a Glucagon-Like Peptide-1 Receptor Analog (GLP-1RA) p. 163 / Sevil Aliyeva and Pamela Schroeder and Paul Sack

Case 40 Simplification of Insulin Regimen Improves Glycemic Control in Elderly Patients With Type 2 Diabetes p. 167 / Maria Gratia Luzuriaga and Rajesh Garg

Case 41 Effects of Glucagon-Like Peptide-1 Receptor Agonist (GLP- IRA) in an Individual With Type 2 Diabetes on High-Dose Insulin Therapy p. 171 / Basem M. Mishriky and Doyle AL Cummings and Carlos E. Mendez

Case 42 Transient Severe Insulin Resistance in COVID-19 and Prediabetes p. 175 / R. Matthew Hawkins and Whitney Adair and Joanna Gibbs and Jennifer Vinh and Cecilia C. Low Wang

Case 43 Nondiabetic Renal Disease in Type 1 Diabetes: When to Consider a Renal Biopsy p. 179 / Rong Mei Zhang and Ritika Puri and Tingting Li and Janet B. McGill

Case 44 Severe Fetal Malformation Related to Obesity and Type 2 Diabetes p. 184 / Aswathi Kumar and Janet B. McGill

Case 45 Hyperglycemia from Oral Comfort Feeds p. 188 / Nehu Parimi and Rajani Gundluru and Michael Gardner and James Sowers

Case 46 Rethinking Insulin in Type 2 Diabetes p. 191 / Rebecca J. Morey and Cynthia Herrick

Case 47 Coincidence or Consequence? A Case of Type 1 Diabetes With Worsening Neuropathy p. 195 / Cecilia C. Low Wang

Case 48 Challenges to the Management of Diabetes in Patients Who Undergo Ventricular Assist Device (VAD) Implantation p. 199 / Chinenye O. Usoh and Donald A. McClain and Barbara A. Pisani

Case 49 Insulin and Heroin: An Unfortunate Mix in an Overlooked Population p. 202 / Amro Ilaiwy and Jennifer V Rowell and Beatrice D. Hong.

Notes:

Includes bibliographical references and index.

Local Notes:

Acquired for the Penn Libraries with assistance from the Louis B. Flexner Medical Book Fund.

ISBN:

1580407668

9781580407663

OCLC:

1242911725